Herbas VPB

Print
EN | LT
LT - CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
EN - CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 403/12
A61K 31/4155
A61P 35/00
European patent
(11) Number of the document 3325468
(13) Kind of document T
(96) European patent application number 16745005.5
Date of filing the European patent application 2016-07-15
(97) Date of publication of the European application 2018-05-30
(45) Date of publication and mention of the grant of the patent 2020-11-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2016/042529
Date 2016-07-15
PCT application publication
(87) Number WO 2017/015124
Date 2017-01-26
Priority applications
(30) Number Date Country code
201562196087 P 2015-07-23 US
201562248408 P 2015-10-30 US
201562264059 P 2015-12-07 US
Inventors
(72)
STANCATO, Louis Frank, US
Grantee
(73) Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, US
Title
(54) CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
  CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
Last update date 2021-05-26